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’ INTRODUCTION
The extracellular matrix (ECM), which includes protein ligands,
such as elastin and fibronectin, is an insoluble macromolecular
complex that forms an environmental substrate outside the cell.15
Cell to ECM contacts play important roles in regulating biolo-
gical processes such as wound healing, organogenesis, and
metastasis.4,5 Integrins are a family of cell adhesion receptors
linking the ECM to intracellular signaling molecules and to the
cytoskeleton network. Intergrins bind to the ECM via ligands
such as fibronectin and laminin. Integrin signaling pathways are
directly involved in cell survival, proliferation, differentiation,
migration, and morphogenesis.13
When designing new biomaterials to be used in tissue
engineering, control of cell-matrix interactions is required. Tirrell
et al. have already reported on artificially, designed analogues of
ECM proteins (aECMs) containing an elastin sequence and the
fibronectin cell binding domain (CS5).6 These proteins have
been produced in bacteria using a T7 expression system. They
also examined how these aECMs affect the adhesive behavior of
human umbilical vein endothelial cells (HUVEC).6 The elastin-
like sequences give these materials elasticity and mechanical
integrity.6b,d While most researchers are utilizing integrin-ligand
recognition to construct new fibronectin-based aECMs, natural
fibronectins are high molecular weight glycoproteins found in
many extracellular matrices (ECMs) and blood plasma.4,5,7
Cell adhesion and cell spreading on fibronectin, either when it
coats a plate or is present in the extracellular matrix, are mediated
by integrin receptors, such as R5β18 and R4β1.9 The sequence
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ABSTRACT: In vivo incorporation of phenylalanine (Phe) analogues into
an artificial extracellular matrix protein (aECM-CS5-ELF) was accom-
plished using a bacterial expression host that harbors the mutant pheny-
lalanyl-tRNA synthetase (PheRS) with an enlarged binding pocket.
Although the Ala294Gly/Thr251Gly mutant PheRS (PheRS**) under
the control of T5 promoter allows incorporation of some Phe analogues
into a protein, the T5 system is not suitable for material science studies
because the amount of materials produced is not sufficient due to the
moderate strength of the T5 promoter. This limitation can be overcome by
using a pair of T7 promoter and T7 RNA polymerase instead. In the T7
expression system, it is difficult, however, to achieve a high incorporation
level of Phe analogues, due to competition of Phe analogues for incorpora-
tion with the residual Phe that is required for synthesis of active T7 RNA
polymerase. In this study, we prepared the PheRS** under T7 promoter
and optimized culture condition to improve both the incorporation level of
recombinant aECM protein and the incorporation level of Phe analogues.
Incorporation and expression levels tend to increase in the case of
p-azidophenylalanine, p-iodophenylalanine, and p-acetylphenylalanine. We evaluated the lower critical transition temperature,
which is dependent on the incorporation ratio and the turbidity decreased when the incorporation level increased. Circular
dichromismmeasurement indicated that this tendency is based on conformational change from random coil to β-turn structure. We
demonstrated that polyethylene glycol (PEG) can be conjugated at reaction site of Phe analogues incorporated. We also
demonstrated that the increased hydrophilicity of elastin-like sequences in the aECM-CS5-ELF made by PEG conjugation could
suppress nonspecific adhesion of human umbilical vein endothelial cells (HUVEC).
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motif, REDV, found within the CS5 domain, is thought to be the
sequence of shortest length capable of R4β1 integrin binding.9b
In Tirrell’s studies on aECMs,6c,e specific HUVEC adhesion and
spreading were dependent on the presence of the CS5 domain of
fibronectin, while there is nonspecific cell binding to elastin. We
hypothesize that the nonpolar nature of the elastin domain is
related to nonspecific cell binding to elastin. We expect, there-
fore, that by increasing the hydrophilicity of the elastin-type
sequences within an aECM by chemical modification, e.g.,
conjugation of PEG (PEGylation) or glycosylation, nonsequence
specific adhesion could be minimized or eliminated (Figure 1).
Non-natural amino acids containing a reactive functional
group10 incorporated into an aECM at one or more predeter-
mined sites could be used to generate a scaffold to which
hydrophilic substituents, such as PEGs and sugars, could be
added while maintaining the structural integrity of the protein.
Incorporation of phenylalanine (Phe) analogues with a reactive
functional group into a recombinant protein, which enables
chemical modification via “click” reactions, Heck reactions, or
Sonogashira couplings, has been accomplished using a bacterial
expression host that harbors a mutated phenylalanyl-tRNA
synthetase (PheRS) with an enlarged binding pocket.11 This
Ala294Gly mutant of PheRS (PheRS*) has been shown to
introduce a set of Phe analogues into a target protein. For this
system the transcription was controlled by a T5 promoter.11
Unfortunately, the T5 expression system is not suitable for
material science studies, because the amount of materials pro-
duced is not sufficient due to the moderate strength of the T5
promoter. However, this limitation can be overcome using a pair
of T7 promoter and T7 RNA polymerase. The T7 RNA
polymerase has greater activity and is more selective than the
endogenous E. coli RNA polymerase.12 To date, only the Phe
analogue, p-azidophenylalanine (pN3Phe), has been successfully
incorporated into a recombinant protein,11c possibly owing to
the complexity of the T7 expression system. When both the T7
polymerase gene and its promoter are present in the same
plasmid, the plasmid is unstable and destroys the host cell.12
Therefore, the T7 expression system (pET system) is con-
structed so that the T7 polymerase gene resides in the E. coli
chromosome and the polymerase is induced by addition of
isopropyl β-D-1-thiogalactopyranoside (IPTG). The T7 promo-
ter, which is placed upstream of the target protein gene, resides in
the pET plasmid. Residual T7 polymerase activity is inhibited by
T7 lysozyme, which is constitutively expressed at low levels and
whose gene is encoded in either pLysS or pLysE plasmid.13,14
The pET system is capable of producing large amounts of
proteins (up to 100 mg/L of culture medium; Scheme 1).
If a Phe analogue is to be incorporated into a protein during
synthesis, Phe must be absent so that it does not compete with
the analogue. Prior to transcription by T5 polymerase of a target
Figure 1. Amino acid sequence of the aECM-CS5-ELF-F protein (A) and incorporated phenylalanine analogues (B).
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gene, we can effectively remove any residual Phe by washing the
cells with 0.9% NaCl aqueous solution several times, called
medium shift. However, when the pET system is used, it is
difficult to achieve high level incorporation of non-natural amino
acids using medium shift. No amino acids can be omitted in
order to induce expression of recombinant proteins in the pET
system, because all twenty naturally occurring amino acids are
essential for the synthesis of active T7 RNA polymerase.
Tirrell et al. usually add IPTG to synthesize T7 RNA poly-
merase for just 10 min prior to the addition of Phe analogue.6
However, 10 min may not be enough time to completely
consume the residual Phe. Increasing the induction time prior
to the Phe analogue addition will lead to a substantial amount
of the target protein deficient of the non-natural amino acid
would be synthesized.
Tirrell et al. previously identified mutations that enlarge the
Phe-binding cavity of E. coli PheRS, Thr251Gly, and Ala294Gly,
and produced the corresponding Ala294Gly11a and Ala294Gly/
Thr251Gly11b mutants (PheRS* and PheRS**, respectively). The
Thr251Gly/Ala294Gly double mutant, PheRS**, effectively in-
corporated p-acetylphenylalanine (pAcPhe) into mouse dihy-
drofolate reductase when the T5 system is used, whereas PheRS*
did not.11b For this study, we prepared both PheRS* and PheRS**
and compared their ability to incorporate Phe analogues into an
aECM using the pET system. Furthermore, we performed
PEGylation of the aECM using click strategy and showed that
the increased hydrophilicity made by PEGylation of the elastin
domain results in lowered nonspecific adhesion of human
umbilical vein endothelical cell (HUVEC).
’EXPERIMENTAL PROCEDURES
Materials. pN3Phe and p-iodophenylalanine (pIPhe) were obtained
from Bachem AG. p-Bromophenylalanine (pBrPhe) was from Fluka.
p-Cyanophenylalanine (pCNPhe)was obtained fromWatanabeChemical
(Hiroshima, Japan). The 20 natural amino acids were obtained from
Aldrich. Cell culture midium and Trypsin/EDTA solution were ob-
tained from Lonza. Crystal violet was obtained from Wako. GREDVY
peptide was prepared by Fmoc solid-phase peptide synthesis in our
laboratory and characterized by MALDI-TOF mass measurement
(H2N-GREDVY-COOH + Na
+: m/z = 762.2).
Measurements. The 1H NMR spectra of the aECMs were
measured at ambient temperature using a Bruker DPX-600 (600 MHz)
spectrometer. Matrix-assisted laser desorption/ionization time-of-flight
(MALDI-TOF) mass spectra were measured on a Voyager RN using
dithranol as a matrix reagent. To generate sodium-cationized ions ([M +
Na]+), NaI was used as a cationization salt. The purity and molecular
weight of purified CS5ELF were confirmed by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE). FT IR spectra were recorded in KBr disks
using a JASCO FTIR-430 spectrometer.
Preparation of p-Ethynyl-L-phenylalanine (pEthPhe).15
Trimethylsilylacetylene (1 mL, 7.2 mmol) was added to a stirred
suspension of N-t-Boc-4-iodo-L-phenylalanine methyl ester (2.45 g,
6.1 mmol), PdCl2(PPh3)2 (40.5 mg, 0.06 mmol), and CuBr (17 mg,
0.12 mmol) in triethylamine (60 mL) kept under nitrogen. The mixture
was stirred at ambient temperature for 12 h and then diluted with water.
This aqueous solution was extracted with diethyl ether (50 mL) and the
organic layer was washed with water (50 mL), dried (MgSO4), and
evaporated. A total of 2 equiv of tetrabutylammonium fluoride 3 3H2O
were added to the solution of dry THF (120 mL) under nitrogen. The
mixture was stirred at 78 C for 2 h. The mixture was then removed
from the cooling bath, H2O (30 mL) was added, and the THF present
was evaporated from themixture under a reduced pressure. The aqueous
solution was extracted with diethyl ether (50 mL) three times; and the
organic layer was washed with a saturated NaCl solution (50 mL), dried
(MgSO4), and evaporated (1.0 g, 39% yield, protected pEthPhe). Aqueous
NaOH(1.5 equiv per ester linkage) was added to a solution of the protected
pEthPhe (1.0 g, 3.3 mmol) that had been dissolved in CH3OH (25 mL) at
ambient temperature. The reaction continued until no starting compound
was detected using TLC (ethyl acetate; 2 h). The pHwas adjusted to 7.0 by
the addition of 0.5 M NaHSO4. The aqueous solution was extracted with
ethyl acetate; the organic layer dried (MgSO4) and evaporated to yield the
amino acid. The product was added to a solution of dryHCl (2.5M) in 1,4-
dioxane at ambient temperature. Themixture was stirred for 24 h. During
that time, the amino acid precipitated as hydrochloride. The product was
isolated and dried in vacuo (0.7 g, 95% yield). 1HNMR(δ, D2O) 3.21 (1H,
dd, 7.7 and 7.8Hz,CHH), 3.36 (1H, dd, 5.6 and 5.6Hz,CHH), 3.53 (1H, s,
CH), 4.25 (1H, dd, 5.8 and 5.8 Hz, CH), 7.32 (2H, d, 8.2 Hz, aromatic),
7.57 (2H, d, 8.2 Hz, aromatic).
Scheme 1. T7 Expression System
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Preparation of p-Acetyl-L-phenylalanine (pAcPhe). A round-
bottom flask, equipped with a stirring bar, was charged with AlCl3 (11.3 g,
85 mmol) and acetylchloride (6.8 mL, 95 mmol), and cooled to 0 C. In a
second flask, protected Phe (acetyl-L-phenylalanine ethyl ester, 4.0 g, 17.0
mmol) was dissolved in CH2Cl2 (16 mL) and cooled to 0 C. The two
solutionsweremixed and stirred at 25 C for 24 h. The reactionmixturewas
poured over ice (100 g) containing 5mLof concentratedHCl. The product
was extracted with CH2Cl2 (200mL) and washed withNaHCO3-saturated
water and water successively. The organic layer was dried over Na2SO4 and
evaporated. Using silica gel chromatography with a mobile phase of ethyl
acetate/hexane (8/2, v/v), the crude productwas purified as awhite powder
(4.3 g, 92% yield); Rf = 0.13 (ethyl acetate/hexane = 2/1, v/v).
1H NMR
(δ, CDCl3) 1.25 (3H, t, 7.2 Hz, OCH2CH3), 2.58 (3H, s, COCH3), 3.14
and 3.23 (2H, 2dd, 13.8, 5.7 and 13.8, 6.0Hz,COCH2), 4.18 (2H, q, 7.2Hz,
OCH2CH3), 4.89 (1H, dd, 6.3 and 13.5 Hz, CHCO), 5.95 (1H, d, 6.6 Hz,
NH), 7.21 (2H, d, 8.1 Hz, aromatic), 8.00 (2H, d, 8.1 Hz, aromatic). The
protected pAcPhe (2.0 g, 7.2 mmol) was deprotected by refluxing in 9 N
HCl (27 mL) for 6 h and the solvent was evaporated, leaving behind a pale
yellow solid (1.65 g, 94% yield). 1HNMR (δ, D2O) 2.66 (3H, s, COCH3),
3.28 and 3.41 (2H, 2dd, 16.5, 7.2 and 12.6, 5.7 Hz, COCH2), 4.30 (1H, dd,
6.0 and 7.8Hz,CHCO), 7.47 (2H, d, 8.4Hz, aromatic), 7.87 (2H, d, 8.4Hz,
aromatic).
Plasmid Constructions. The incorporated polylinker encodes a
T7-tag, a hexahistidine tag, and an enterokinase cleavage site. This linker
was cloned into a pET28 plasmid between theNco I and Xho I sites. The
pET28-CS5-ELF-PheRS* plasmid11c was used as a template for a
polymerase chain reaction (PCR) mutagenesis to create the coding
sequence for PheRS**. This new plasmid was designated pET28-
CS5-ELF-PheRS**. The primers used to introduce the mutation
were 50 CTTCCTACTTCCCGTTTGGCGAACCTTCTGCAGAAG
30 (FS_TG_f) and 50 CTTCTGCAGAAGGTTCGCCAAACGG-
GAAGT AGGAAG 30 (FS_TG_r). The DNA sequencing primer used
was 50 GCC GAT GTT CCA TCA GAT GGA AGG 30 (efs_seq_f2).
Incorporation of Phe Analogues into the aECM-CS5-ELF.
Buffer and media were prepared according to standard protocols. A
phenylalanine auxotrophic derivative of E. coli BL21(DE3), designated
AF [HsdS gal (ncIts857 ind 1 Sam7 nin5 lacUV5-T7 gene 1) pheA] and
constructed in Tirrell laboratory, was used as the expression host. The
AF strain was transformedwith the repressor plasmid pLysS-IQ andwith
pET28-CS5-ELF-PheRS* or with pET28-CS5-ELF-PheRS** to afford
the expression strains AF-IQ[pET28-CS5-ELF-PheRS*] or AF-IQ-
[pET-CS5-ELF-PheRS**], respectively. We investigated the in vivo
translational activities of the Phe analogues, [pN3Phe, pBrPhe, pIPhe,
pEthPhe, pCNPhe, and pAcPhe] (Figure 1). M9minimal medium (1 L)
supplemented with 0.4% glucose, 35 mg/L thiamine, 0.1 mM MgSO4,
0.1 mM CaCl2, the 20 naturally occurring amino acids (at 40 mg/L
each), and antibiotics (kanamycin 25 mg/L, chloramphenicol 20 mg/L)
was inoculated with 300 mL of culture containing the expression strain.
When the optical density at 600 nm reached 0.71.0, a medium shift was
performed. Cells were sedimented by centrifugation for 7 min at 20100 g,
4 C, and the supernatant was removed. Cells were resuspended in
supplemented M9medium deficient of Phe and Trp. Protein expression
was induced after the medium shift by IPTG to a final concentration of
1 mM. After 10 min, a Phe analogue was added at a concentration of
50250 mg/L. Cells were cultured for 4 h postinduction and protein
expression was monitored by SDS polyacrylamide gel electrophoresis
(PAGE) using a normalized OD600 of 0.5 per sample.
Protein Purification (for 1 L of Culture). The purification
scheme, which takes advantage of the inverse temperature transitions of
the aECMs, has been reported.6b Briefly, the wet cell mass was dispersed
in TEN buffer at a concentration of 1 g/mL, frozen, and defrosted at
4 Cwith addition of 1.0 μg/mL DNase, 10 ng/mL RNase, and 50 ng/mL
PMSF. The aECMs, which had partitioned into the pellet of the
whole-cell lysate after centrifugation (20100 g, 60 min, 37 C), were
resuspended in 4 M urea. The solutions were centrifuged (20100 g,
60 min, 4 C) to remove nonprotein cellular debris and then dialyzed
against water (3 days, 4 C). The precipitates were removed by cen-
trifugation (20100 g, 60 min, 2 C), and the clarified retentates were
then lyophilized. The purity of the proteins and the uniformity of their
molecular weights were confirmed by SDS-PAGE. The relative amounts
of the Phe analogues incorporated were derived from the areas of their
600 MHz 1H NMR spectral aromatic peaks (Table 1).
LCST Measurements. The LCST values were measured using
1 mg aECM/mL aqueous solutions. The temperature was increased at a
rate of 1 C/min while the percent transmission at 350 nm of the
solution was measured using a V-550 spectrometer.
CDMeasurements. The CD spectra were measured using 0.02mg
aECM/mL aqueous solutions, a 1 mm quartz cell, and a Jasco J820K
spectropolarimeter.
Preparation of PEG-Alkyne. PEG-Alkyne were prepared in two
steps from mono methyl poly(ethylene glycol) (Aldrich, Mn = 550).
Ring opening of succinic anhydride (1 mmol) by the monomethyl PEG
(1 mmol) in the presence of 4-(dimethylamino)-pyridine (DMAP) gave
the PEG-COOH at reflux condition. This was followed by esterification
with propargyl alcohol (2 mmol) under dicyclohexylcarbodiimide
(DCC) coupling conditions (89% yield). The structure was confirmed
by 1H NMR measurement. NMR data were as follows: 1H NMR (200
MHz, CDCl3, δ, ppm): 2.49 (t, 1H, J = 2.3 Hz, CH2CCH), 2.69 (s, 4H,
COOCH2CH2COO), 3.38 (s, 3H, CH3OCH2), 3.64 (s, OCH2CH2O),
4.7 (d, 2H, J = 2.5 Hz, COOCH2CCH).
PEGylation of aECM-CS5-ELF-N3. A typical click reaction pro-
cedure was performed as follows. In a round-bottom flask, aECM-
CS5ELF-N3 (67% incorporation, 10 mg, 2.38 104 mmol, azido unit
2.39 103 mmol), PEG-alkyne (2.3 mg, 3.29 103 mmol), THPTA
(34 mg, 7.8 102 mmol), and 4 mL of PBS were added in the mixture.
Next, with the contents of the flask contained under a nitrogen atmo-
sphere, 3.4 mg (2.4 102 mmol) of CuBr was added. After stirring the
mixture at 25 C for 3 days, the reaction mixture was dialyzed at 4 C for
3 days and lyophilized.
Preparation of Cross-Linked aECM-CS5-ELF-N3/aECM-
CS5-ELF-PEG Substrate for HUVEC Cultivation. aECM-CS5-
ELF-N3/aECM-CS5-ELF-PEG (3.4 mg/0 mg, 1.57 mg/1.83 mg, and
0.6 mg/2.8 mg) were dissolved in water (1 mL) to prepare solution with
respective ratio of protein (1/0, 1/1, or 1/4, mol/mol). The solutions
Table 1. Extent of Phe Analoguesa Expressed CS5ELF
Phe analogue
PheRS
mutantb
yield of CS5ELFc
(mg/L culture)
Phe analogd
(%)
pN3Phe PheRS* 18 43
pN3Phe PheRS** 22 67
pBrPhe PheRS* 8 52
pBrPhe PheRS** 11 55
pIPhe PheRS* 6 40
pIPhe PheRS** 14 58
pEthPhe PheRS* 3 34
pEthPhe PheRS** 5 45
pCNPhe PheRS* 12 33
pCNPhe PheRS** 8 36
pAcPhe PheRS* 14 37
pAcPhe PheRS** 12 44
aAdded amount of Phe analogues in to the cell cultures: 250 mg/L.
bMutated phenylalanyl-tRNA synthetase: PheRS*, Ala294Gly; PheRS**,
Thr251Gly/Ala294Gly. cYield of aECM containing Phe analogues from
1 L cultivation. dDetermined by 600MHz 1HNMR spectra measurement
in DMSO-d6.
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were centrifuged (20100 g, 1 min) and they (150 μL) were dropped on
40  15 Petri dishes. The dishes were spin-coated at 1500 rpm for 40 s
on aMIKASA 1H-D7 spin coater and dried at 40 C for 4 h. Dried dishes
were irradiated using TOSHIBA H-400F, H-400P mercury-vapor lamp
for 30 min to cross-link. The dishes were immersed in cold water for 20 s
followed by in ethanol 5 s and dried at 40 C for 20 min.
Cell Culture. HUVECs (Lonza Walkersville, Inc.) were maintained
in a 37 C, 5% CO2 humidified environmental chamber. The cells were
grown in Endothelial Growth Medium-2 (EGM-2, 2% FBS; Lonza
Walkersville), which was replaced every 2 days. Near confluent HUVEC
cultures were passaged by treatment with 0.025%Trypsin/0.01% EDTA
(Lonza Walkersville).
Cell Spreading. HUVECs in EGM-2 were added to 40 15 mm
Petri dish at a concentration of 5000 cells per Petri dish. After 3 days, the
plates were removed from the environmental chamber and cells were
imaged using a 10 phase contrast objective on a Nikon Eclipse TS100/
TS100-F epifluorescence microscope (Tokyo, Japan).
Cell Resistance to Detachment. HUVECs incubated 3 days in
EGM-2 (Endothelial Growth Medium-2) were added to Petri dish. A
solution of the GREDVY peptide in PBS (1.5 mM) was added. After 30
min of incubation at 37 C and 5% CO2, nonadherent cells were
removed by inversion of the plate and rinsing with PBS. Cells were
stained with crystal violet and thoroughly rinsed with water. The dye was
solubilized using a 1% SDS solution. The absorbance was measured at
595 nm on a Jasco J820K spectropolarimeter. At least three independent
experiments were carried out in order to check the reproducibility.
’RESULTS AND DISCUSSION
Incorporation of Phe Analogues into aECM-CS5-ELF-F.
Incorporation of non-natural amino acids into proteins can be
used to substantially change their physical properties; addition-
ally, specific chemical modification at multiple sites can be made
for a predetermined type of amino acid. For this study, the Phe
(underlined) in the ELF sequence (VPGVG)2VPGFG(VPGVG)2
6
of the aECM, aECM-CS5-ELF-F, was replaced with pN3Phe,
11c
pBrPhe, pIPhe, pEthPhe, pCNPhe, or pAcPhe, generating the
proteins aECM-CS5-ELF-N3, aECM-CS5-ELF-Br, aECM-CS5-
ELF-I, aECM-CS5-ELF-Eth, aECM-CS5-ELF-CN, or aECM-
CS5-ELF-Ac, respectively (Figure 1). The aECMs contain the
elastin-like repeats of ELF interspaced with the CS5 domain of an
alternatively spliced connecting segment III of fibronectin as
-(CS5-ELF5)3-. The elastin domain provides the biomaterials
mechanical strength, while the fibronectin CS5 domain serves as
a platform for HUVEC attachment and spreading.6 A T7 tag leader
sequence was included to increase expression levels and to aid in
protein detection. A hexahistidine tag (His tag) was also introduced,
providing an alternate method of purification (Figure 1).
For this work, a plasmid encoding PheRS** was created by
PCR amplification and mutagenesis using the plasmid, pET28-
CS5-ELF-PheRS*, which encodes PheRS*.11c These plasmids
also encode the aECM-CS5-ELF-F gene, as described in detail
above, and are designated pET-CS5-ELF-PheRS* and pET-CS5-
ELF-PheRS** for the single- and double-site mutants, respec-
tively (Figure 1). The sequence of pET-CS5-ELF-PheRS** was
confirmed by DNA sequencing (Supporting Information, 1).
The phenylalanine auxotrophic E. coli strain (AF) carrying the
repressor plasmid pLysS-IQ, AF-IQ, was transformed with pET-
CS5-ELF-PheRS* or pET-CS5-ELF-PheRS** to generate the
expression systems AF-IQ[pET-CS5-ELF-PheRS*] or AF-IQ-
[pET-CS5-ELF-PheRS**], respectively.
Expression of aECM-CS5-ELF-F was under control of an
inducible T7 promoter. The expression system was induced with
IPTG and cultivated for an additional four hours. Whole cell
lysates and purified aECM proteins were analyzed by SDS-
PAGE. The gels show a significant amount of an ECM protein
with a calculated molecular weight of 42.6 kDa. Western blot
analysis of purified aECM-CS5-ELF-F was visualized using a
horseradish peroxidase-conjugated T7 tag antibody, confirming
that the protein contains a T7 tag leader (Supporting Informa-
tion, 2). When PheRS* and PheRS** were used, the Phe
analogues (250 mg/L culture) were readily incorporated into
aECM-CS5-ELF and, in most cases, produce >10 mg of the
target proteins from 1 L culture (Table 1). Analysis of the 1H
NMR spectrum of aECM-CS5-ELF-N3 showed that incorpora-
tion level amounts of pN3Phe were 43 and 67% when PheRS*
and PheRS** were used, respectively (Figure 2A). These incor-
poration level are derived from the ratio of the areas of the
aromatic signal at 7.20 (s) ascribed to Phe and the signal at 6.98
ppm (d, 8.1 Hz) ascribed to pN3Phe. Incorporation of pBrPhe,
yielding aECM-CS5-ELF-Br, was performed in the same man-
ner. New aromatic signals were observed at 7.17 ppm (d, 7.6 Hz)
and 7.40 ppm (d, 7.8 Hz) in its 1H NMR spectrum (Figure 2B).
For PheRS*, the relative amount of pBrPhe incorporated is 52%,
while PheRS** incorporates pBrPhe at a level of 55%. The 1H
NMR spectra of aECM-CS5-ELF-Eth and aECM-CS5-ELF-CN
also show new signals at 7.33 ppm (d, 6.4 Hz) for pEthPhe and at
6.99 ppm (d, 7.8 Hz) and 7.42 ppm (d, 8.1 Hz) for pCNPhe
(Figures 2C), respectively. Both PheRS* and PheRS** allow
lower levels of pEthPhe and pCNPhe incorporation than those
for the previously discussed Phe analogs (see Table 1). The
most remarkable difference in the incorporation levels of Phe
Figure 2. Expanded 1H NMR spectra (in DMSO-d6 at ambient
temperature) of purified aECM-CS5-ELF-N3 (A), Br (B), CN
(C), and I (D) biosynthesized (added Phe analogues: 250 mg/L)
using PheRS* (blue line) and PheRS** (red line) as the mutated
phenylalanyl-tRNA synthetases and aECM-CS5-ELF-F (black line).
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analogues between twomutant PheRSs is observed for pIPhe, the
incorporation levels of pIPhe with PheRS** (58%, Figure 2D) is
greater than that with PheRS*. It seems that mutations in PheRS
as well as p-substituent influence to what extent the Phe analogue
is incorporated, given that all other expression and purification
conditions were identical. PheRS** shows over 200-fold greater
activation rate of pIPhe than PheRS* in vitro.16
When the amount of added pN3Phe was increased from 50 to
100mg/L, the incorporation level also increased for both PheRS*
and PheRS** was used (Figure 3). This improved incorporation
ratio was especially noticeable in the case of the PheRS**
experiment (red plot, Figure 3) and indicated that double G
mutations are also effective for in vivo incorporation of the both
Phe analogues (pN3Phe and pIPhe) in T7 expression system,
because PheRS** apparently has a large enough recognition site.11b
The acetylated derivative of Phe, pAcPhe, was synthesized
using FriedelCrafts acylation and subsequent deprotection.
Because pAcPhe was poorly incorporated into proteins in vivo
when PheRS* under the control of the T5 promoter was used,
PheRS** was required for in vivo incorporation in the T5
expression system.11b In contrast, in the T7 expression system,
both PheRS* and PheRS** allow similar incorporation levels of
pAcPhe into aECM-CS5-ELF protein (37 and 44%, respec-
tively), likely due to the enhanced expression level of PheRS*
overcoming a kinetic barrier of pAcPhe activation (Table 1). The
pAcPhe-substituted aECMs (aECM-CS5-ELF-Ac) expressed
using either PheRS* or PheRS** was purified to homogeneity
by exploiting their lower critical solution temperature (LCST)
behavior. An analysis of the 1HNMR spectrum of aECM-ELF-Ac
synthesized using PheRS** indicates that 44% of phenylalanines
are replaced by pAcPhe, which corresponds to approximately 6.6
pAcPhe residues per polymer (Figure 4). It is revealed that pAcPhe
can be successfully incorporated into recombinant proteins in vivo
using the T7 expression system, as well as the T5 expression system.
Lower Critical Solution Temperature (LCST) Behavior and
CD Spectra. A distinguishing property of elastin-like polypep-
tides from other polypeptides in water is that they are miscible at
all concentrations below a lower critical solution temperature
(LCST). Furthermore, this miscibility behavior is reversible.17
For aECM-CS5-ELF-F (1 mg/mL; Figure 5), the LCST value is
34 C. The secondary structures of elastin-like polypeptides are
characterized by a high proportion of random coils and a low
proportion of β-turns18 at low temperatures. This distribution
gradually inverts with increasing temperature. These structural
features are reflected in the CD spectra of aECM-CF5-ELF-F at
low temperatures by a distinct minimum at 197 nm and a less
pronounced minimum at 218 nm (Figure 6), which are asso-
ciated with the presence of random coils and β-turns, respec-
tively. With increasing temperature, the random coil signal
becomes less pronounced, while that of the β-turn increases,
indicating a transition from a less ordered to a more ordered
secondary structure state (Figure 6).
However, the LCST value of aECM-CS5-ELF protein is
changed when Phe analogues are produced. Both aECM-CS5-
ELF-N3 (47% incorporation) and aECM-CS5-ELF-CN (36%
incorporation), prepared using PheRS**, have LCST values of
Figure 3. Incorporated ratios determined by 1H NMR spectra of purified aECM-CS5-ELF-I (left) and aECM-CS5-ELF-I (right) in DMSO-d6 at
ambient temperature as a function of added pN3Phe (left) and pIPhe (right; mg/L) using PheRS* (blue plot) and PheRS** (red plot) as the mutated
phenylalanyl-tRNA synthetases.
Figure 5. LCST measurements on aECM-CS5-ELF-F (black), N3
(47%, purple), and CN (36%, green) at the concentrations of 1 mg/
mL in H2O.
Figure 4. Expanded 1HNMR spectra of purified aECM-CS5-ELF-Ac in
DMSO-d6 at ambient temperature biosynthesized (added Phe analo-
gues: 250 mg/L) using PheRS* (blue line) and PheRS** (red line).
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32 C (Figure 5). The CD spectra of these two aECMs (Figure 7)
demonstrate that the two aECMs retain the characteristics
associated with proteins of mixed random coil/β-turns, although
in both cases there appears to be an increased amount of β-turns
at low temperature in comparison with aECM-CS5-ELF-F and
the random coil signal is lost as the temperature increases. The
solutions of both polypeptides become turbid at 32 C. The
LCST values for aECM-CS5-ELF-Br (55% incorporation) and
aECM-CS5-ELF-I (58% incorporation) prepared using PheRS**,
decreased significantly to 16 and 18 C (Figure 8), respectively,
and their CD spectra no longer resembled proteins with random
coil/β-turn secondary structures. Instead, the spectra showed
double minima at 204 and 222 nm, indicating increased propor-
tions of R-helices. Additionally, the spectra were unaffected by
temperature (Figure 9). These results indicate that the introduc-
tion of pBrPhe, pIPhe, or AcPhe can alter the secondary structure
of the parent protein. The LCST value for aECM-CS5-ELF-Br
(52% incorporation) was 19 C, whereas for aECM-CS5-ELF-I
(30% incorporation), the LCST value was 33 C. This suggests
that the LCST value is affected by incorporation ratio.
PEGylation of aECM-CS5-ELF-N3 and Photo-Cross-Link-
ing. Click reaction of CS5-ELF-N3 (67% incorporation) and
PEG-alkyne (Mn = 550) were carried out under a nitrogen at-
mosphere at 25 C.After the reaction, the peaks assigned to aromatic
proton of N3Phe unit at 6.98 ppm and 7.26 ppm disappeared
completely, indicating that all N3Phe units were PEGylated and
so the aECM protein containing N3Phe was PEGylated at the
reaction sites. In this study, the density of PEGylated elastin
domain is controlled by blending aECM-CS5-ELF-N3 (67%)
Figure 6. CD spectra of aECM-CS5ELF-F at the concentration of
0.02 mg/mL in H2O.
Figure 7. CD spectra of aECM-CS5-ELF-F (black), N3 (47%,
upper), and CS5ELF-CN (36%, bottom) at the concentration of 0.02
mg/mL in H2O.
Figure 8. LCSTmeasurements onCS5ELF-F, CS5ELF-Br (52 and 55%),
and CS5ELF-I (30 and 58%) at the concentration of 1 mg/mL in H2O.
Figure 9. CD spectra of CS5ELF, CS5ELF-Br (52 and 55%), and
CS5ELF-I (30 and 58%) at the concentrations of 0.02 mg/mL in H2O.
Figure 10. Cell morphology after 0 days on (a) blank, (b) positive
control [commercially available cultivation dish], (c) cross-linked
aECM-CS5-ELF-N3, (d) cross-linked blend of aECM-CS5-ELF-N3/
aECM-CS5-ELF-PEG (1/1, mol/mol).
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with aECM-CS5-ELF-PEG (67%) and the blended films are
photo-cross-linked by UV irradiation.
Cell Spreading. According to previous papers,6b,c cell spread-
ing on cross-linked aECM film is dependent on the REDV
domains. HUVECs plated on PEGylated films were monitored at
1 day intervals by phase contrast microscopy and were categor-
ized as dark (spread). On films containing 3355% of PEGy-
lated Phe in the elastin domain prepared by blending aECM-
CS5-ELF-N3 (67%) with aECM-aECM-CS5-ELF-PEG (67%),
in which the pN3Phe unit act as the photosensitive cross-linker
via nitrene chemistry, the cells spread within 1 day (Figure 10).
When compared with positive control cultured on commercially
available cultivation dish [Cell Desk (Nunc, Inc.), Figure 10b],
the percentage of well spread cells on cross-linked aECM-CS5-
ELF-N3 (67%) was higher at days 0 and 1, indicating that REDV
segment acted as cell-binding segment. On the other hand, films
containing 33% of PEGylated Phe unit, prepared by a blend
(aECM-CS5-ELF-N3/ aECM-CS5-ELF-PEG = 1/1, mol/mol),
also showed adhesion of HUVEC (Figure 10d) and increasing
the aECM-CS5-ELF-PEGcontent resulted in a significant reduction
in the extent of cell spreading (Figure 11). After observation by
microscopy, cells were stained with 0.5% crystal violet19 aqueous
solution for 10 min to quantify the adhered cells. According to the
reported procedure,19 dishes were washed with water to remove the
bright, rounded (not spread) cells and dried at 37 C. Subsequently,
1% sodium dodecyl sulfate solution was added, and dissolved the
cells for 1 h and the absorbance at 595 nm ascribed to crystal violet
from spread cells was estimated using UV/Vis spectrophotometer.
Competitive Peptide Inhibition. To test the hypothesis that
HUVEC adhere to the cross-linked film through the REDV cell-
binding domain and the nonspecific cell adhesion can be
suppressed by the PEGylation or not, competitive peptides were
used to inhibit adhesion. Tirrell et al. previously showed that cell
adhesion to absorbed aECM proteins is dependent upon the
presentation of authentic cell-binding domains.6 In contrast, in
the absence of PEGyated aECM, cross-linked protein film exhibit
significant nonspecific adhesion.6 After HUVEC were incubated
on the cross-linked film, subsequent washing using cold 1.5 mM
of the competitive GREDVY20 peptide in PBS was carried out.
The number of cells adherent to cross-linked aECM-CS5-ELF-
N3 (HUVEC was incubated on the cell culture Petri dish) in the
absence of peptide to normalize for passage-to-passage variations.
After washing, significant nonspecific adhesion was observed in the
cross-linked aECM-CS5-ELF-N3 film, but nonspecific adhesionwas
remarkably decreased in the PEGylated cross-linked film (Figure 11).
The negative control peptide GRDEVY had no significant effect
on the number of adherent cells to aECM. Furthermore, in-
creasing GREDVY from 1.5 to 3.0 mMdecreased the numbers of
adherent HUVEC to the film. The results demonstrate that
HUVECs specifically adhere to the REDV cell cell-binding
domain in the cross-linked film, and that the nonspecific adhe-
sion was suppressed by the PEGylation via click reaction.
’CONCLUSIONS
The results of the studies presented herein provide a new tool
for the de novo design of “intelligent aECMs” that might be used
in small-diameter vascular graft construction. PEGs chemically
coupled to Phe analogs incorporated into aECM-CS5-ELFs via
“click” reactions could fine-tune the adhesion behaviors of
HUVEC/aECM-CS5-ELF systems.
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